Are Ketamine Clinics Paving the Way for Legal Psychedelic Therapy?

This DoubleBlind article looks at the rapid growth of ketamine clinics in the United States and asks whether they may become a template for legal psychedelic therapy. It describes how some clinics combine ketamine infusions with psychotherapy, while others offer a more limited medical model. The piece also summarizes the expected expansion of psychedelic medicines, including MDMA and psilocybin, and the regulatory uncertainty around how these treatments may be delivered. It references clinic operators, researchers, and advocates discussing infrastructure, training, and access. This content is most relevant for readers interested in psychedelic therapy, clinic models, and the future regulation of legal psychedelic medicines.